IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
Martin
Craig A
CA
Morita
Kazumi
K
Ribes
Julie A
JA
Deshpande
Lalitagauri M
LM
Sader
Helio S
HS
Castanheira
Mariana
M
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006761:Hospitals; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D007629:Kentucky; D008297:Male; D008800:Mexico; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D014481:United States; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D015378:Imipenem; D001618:beta-Lactamases